Pharmacoepidemiology And Drug Safety

Journal Title：Pharmacoepidemiology And Drug Safety

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include:

design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;

comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;

methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;

assessments of harm versus benefit in drug therapy;

patterns of drug utilization;

relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;

evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

《药物流行病学与药物安全》旨在为药物流行病学领域的数据、方法和观点的交流与评估提供一个国际论坛。该期刊发表同行评审的原创研究报告、受邀评论以及各种客座社论和评论，涵盖药物流行病学和药物安全上市后监测的科学、医学、统计、法律和经济方面。这些类别中的适当材料也可考虑作为简报发表。

特别感兴趣的领域包括：

研究特定药物、生物制剂或医疗器械的益处或安全性的研究的设计、分析、结果和解释，包括药物警戒、上市后监测、药物经济学、患者安全、分子药物流行病学或药物流行病学广泛领域内的任何其他研究；

与药物、生物制剂和医疗器械有关的比较有效性研究。比较效果研究是生成和综合证据，比较预防、诊断、治疗和监测临床状况的替代方法的益处和危害，因为这些方法确实在现实世界中使用；

与药物流行病学相关的方法学贡献，无论是原创贡献、现有方法的评论，还是如何应用药物流行病学方法的教程；

药物治疗中的危害与益处评估；

药物使用模式；

药物流行病学与监管指南的制定和解释之间的关系；

与药品、生物制剂和医疗器械有关的风险管理计划和方案的评估。

Pharmacoepidemiology And Drug Safety创刊于1992年，由John Wiley and Sons Ltd出版商出版，收稿方向涵盖医学 - 药学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 约3月 ，影响因子指数2.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。